A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration

The delivery of nasal drugs specifically to the middle meatus is of critical importance in the medical treatment of rhinosinusitis. In this respect, topical nasal drug administration by drops has generally been perceived to be superior to nasal sprays, although there is a lack of evidence to support this notion. This study aims to compare the intranasal delivery of nasal sprays and drops to the middle meatus in vivo, using a novel quantitative method. A surgical patty was placed in the middle meatus. Radio-labelled topical nasal drops and aqueous sprays were administered in a standardized fashion in normal volunteers (10 nasal cavities). The subsequent absorption of administered radio-labelled saline on the patty was measured using a gamma counter. A randomized prospective crossover design was used for the study. The mean percentage (range) of absorbed administered saline on the swab was 8.7 (0.3–39.5) and 9.7 (0.03–20.4) for the spray and drop administration techniques respectively (p = 0.8). Thus, there is wide variation in the delivery of topical nasal drugs and the perceived superiority of nasal drop administration, in terms of delivery to the middle meatus, may be incorrect.

[1]  P. Keith,et al.  Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  H. Kubba,et al.  The Effect of Head Position on the Distribution of Drops within the Nose , 2000, American journal of rhinology.

[3]  D. Henson,et al.  The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis. , 1999, Clinical otolaryngology and allied sciences.

[4]  J. Homer,et al.  An endoscopic photographic comparison of nasal drug delivery by aqueous spray. , 1998, Clinical otolaryngology and allied sciences.

[5]  D. Heald,et al.  Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  R. Wilson,et al.  Effect of head position on the efficacy of topical treatment of chronic mucopurulent rhinosinusitis. , 1987, Thorax.

[7]  S. Clarke,et al.  Deposition pattern from a nasal pump spray. , 1987, Rhinology.

[8]  S. Clarke,et al.  The nasal distribution of metered does inhalers , 1987, The Journal of Laryngology & Otology.

[9]  H. Stammberger,et al.  Endoscopic Endonasal Surgery—Concepts in Treatment of Recurring Rhinosinusitis. Part I. Anatomic and Pathophysiologic Considerations , 1986, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  R. Chalton,et al.  Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis. , 1985, British medical journal.

[11]  J. Hardy,et al.  Intranasal drug delivery by spray and drops , 1985, The Journal of pharmacy and pharmacology.

[12]  G. Karlsson,et al.  A randomized trial of intranasal beclomethasone dipropionate after polypectomy. , 1982, Rhinology.

[13]  N. Mygind,et al.  Aerosol distribution in the nose. , 1978, Rhinology.

[14]  F. Aoki,et al.  Distribution and removal of human serum albumin-technetium 99m instilled intranasally. , 1976, British journal of clinical pharmacology.

[15]  W. Ahmad,et al.  Nasal polyps. , 2018, British medical journal.